fMRI and IVCM Cornea Microscopy of CXL in Keratoconus

Recruiting Observational Study
Pain, Postoperative Pain, Chronic Pain, Acute Surgical Injury Surgical Wound Cornea Injury Cornea Keratoconus
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
8 – 35
Sex
Any
Study type
Observational
Participants needed
60 (estimated)
Sponsor
Boston Children's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Evaluation of neuroplasticity of pain pathways and corneal afferent nerve regeneration following corneal crosslinking (CXL) in keratoconus patients using fMRI and corneal In Vivo Confocal Microscopy (IVCM).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: CXL Group * Age 8-35 years * Clinical diagnosis of keratoconus and seeking CXL treatment * English speaking ability sufficient to comprehend consent with parental assistance * MRI compatible * Ability to lie still for an MRI session (60 minutes) Control Group * Age 8-35 years…
Contacts

Eric A Moulton, OD PhD

617-919-6827

eric.moulton@childrens.harvard.edu

CONTACT

Nicholas J Pondelis, BA

617-919-1895

nicholas.pondelis@childrens.harvard.edu

CONTACT